These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2813870)

  • 1. The classification of chemical carcinogens.
    Matula TI; Somers E
    Regul Toxicol Pharmacol; 1989 Oct; 10(2):174-82. PubMed ID: 2813870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A classification framework and practical guidance for establishing a mode of action for chemical carcinogens.
    Butterworth BE
    Regul Toxicol Pharmacol; 2006 Jun; 45(1):9-23. PubMed ID: 16530901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Industry efforts to weaken the EPA's classification of the carcinogenicity of 1,3-butadiene.
    Sass JB
    Int J Occup Environ Health; 2005; 11(4):378-83. PubMed ID: 16350472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular effects of chemical carcinogens.
    Williams GM
    Dev Toxicol Environ Sci; 1986; 12():371-82. PubMed ID: 3549238
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk assessment for carcinogenesis promoting agents: need for a weight of all the evidence approach.
    Clayson DB
    Prog Clin Biol Res; 1995; 391():359-67. PubMed ID: 8532728
    [No Abstract]   [Full Text] [Related]  

  • 6. Butylated hydroxytoluene: tumor-promoting activity in an in vitro two-stage carcinogenesis assay.
    Djurhuus R; Lillehaug JR
    Bull Environ Contam Toxicol; 1982 Jul; 29(1):115-20. PubMed ID: 7115989
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of carcinogenicity classifications and evaluations: the case of formaldehyde.
    Binetti R; Costamagna FM; Marcello I
    Ann Ist Super Sanita; 2006; 42(2):132-43. PubMed ID: 17033133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety assessment of butylated hydroxyanisole and butylated hydroxytoluene as antioxidant food additives.
    Williams GM; Iatropoulos MJ; Whysner J
    Food Chem Toxicol; 1999; 37(9-10):1027-38. PubMed ID: 10541460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro system for detecting non-genotoxic carcinogens.
    Dertinger SD; Torous DK; Tometsko AM
    Environ Mol Mutagen; 1993; 21(4):332-8. PubMed ID: 8491212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Report of ICPEMC Task Group 5 on the differentiation between genotoxic and non-genotoxic carcinogens.
    Mutat Res; 1984 Jan; 133(1):1-49. PubMed ID: 6363908
    [No Abstract]   [Full Text] [Related]  

  • 11. Cytotoxicity and apoptosis induction by butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT).
    Saito M; Sakagami H; Fujisawa S
    Anticancer Res; 2003; 23(6C):4693-701. PubMed ID: 14981915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of carcinogenicity of butylated hydroxytoluene on long-term administration to B6C3F1 mice.
    Shirai T; Hagiwara A; Kurata Y; Shibata M; Fukushima S; Ito N
    Food Chem Toxicol; 1982 Dec; 20(6):861-5. PubMed ID: 6891670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotoxic substances also posing a cancer risk: a warning.
    Csicsaky MJ; Rodríguez-Farré E
    Neurotoxicol Teratol; 1990; 12(6):677-81. PubMed ID: 2255316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A proposed framework for assessing risk from less-than-lifetime exposures to carcinogens.
    Felter SP; Conolly RB; Bercu JP; Bolger PM; Boobis AR; Bos PM; Carthew P; Doerrer NG; Goodman JI; Harrouk WA; Kirkland DJ; Lau SS; Llewellyn GC; Preston RJ; Schoeny R; Schnatter AR; Tritscher A; van Velsen F; Williams GM
    Crit Rev Toxicol; 2011 Jul; 41(6):507-44. PubMed ID: 21591905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of 'secondary mechanism' in the regulation of carcinogens; a chronology.
    Scheuplein RJ
    Cancer Lett; 1995 Jun; 93(1):103-12. PubMed ID: 7600537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced tumour development by butylated hydroxytoluene (BHT) in the liver, lung and gastro-intestinal tract.
    Witschi HP
    Food Chem Toxicol; 1986; 24(10-11):1127-30. PubMed ID: 3804115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative trait loci that regulate susceptibility to both butylated hydroxytoluene-induced pulmonary inflammation and lung tumor promotion in CXB recombinant inbred mice.
    Malkinson A; Radcliffe R; Bauer A; Dwyer-Nield L; Kleeberger S
    Chest; 2002 Mar; 121(3 Suppl):82S. PubMed ID: 11893704
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The calculation and use of carcinogenic potency: a review.
    Barr JT
    Regul Toxicol Pharmacol; 1985 Dec; 5(4):432-59. PubMed ID: 3912853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Default assumptions in carcinogen risk assessment used by regulatory agencies.
    Moolenaar RJ
    Regul Toxicol Pharmacol; 1994 Dec; 20(3 Pt 2):S135-41. PubMed ID: 7724845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.